Latest news
Why Nuvation Bio (NUVB) Is Down 8.8% After Surging Q2 2026 Revenue and IBTROZI Data Tease - simplywall.stsimplywall.st · Fri, 07 Aug 2026 12:39:50 GMTNuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:12 GMTNuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:30:00 GMTNuvation Bio (NUVB) surges to $114.9M revenue and issues $250M notes - Stock TitanStock Titan · Thu, 06 Aug 2026 10:55:57 GMTDo IBTROZI’s TRUST Data Shape Nuvation Bio’s (NUVB) Edge in Targeted Lung Cancer Therapy? - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 16:16:18 GMTNuvation Bio will present IBTROZI data across lung cancer subgroups - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTNuvation Bio Inc. (NUVB) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT